Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-09-30
1993-08-24
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530330, 530332, 930DIG780, 930DIG787, 514 19, 514562, 514331, 562426, 562557, A61K 3702, C07K 502
Patent
active
052389227
ABSTRACT:
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.
REFERENCES:
patent: 5043268 (1991-08-01), Stock
Reiss, et al., Proc. Natl. Acad. Sci. USA 88, 732-6 (1991).
Schaber, et al., J. Biol. Chem. 265, 14701-4 (1990).
Goldstein, J. L., et al., "Nonfarnesylated Tetrapeptide Inhibitors of Protein Farnesyltransferase", The Journal of Biological Chemistry, vol. 266, No. 24 pp. 15575-15578 (1991).
deSolms S. Jane
Garsky Victor M.
Graham Samuel L.
Daniel Mark R.
DiPrima Joseph F.
Linnell Eric
Merck & Co. , Inc.
Russel Jeffrey E.
LandOfFree
Inhibitors of farnesyl protein transferase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of farnesyl protein transferase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of farnesyl protein transferase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-829237